Registry of cardiovascular complications in people living with HIV
Official title: Register of Cardiovascular Complications Among People Living With HIV
Run by Saint Antoine University Hospital · NCT02453919 · Data updated 2026-11-12
This study is collecting information from adults living with HIV who have heart health concerns to see how HIV affects their heart and help improve their care.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 800 (estimated) |
| Sponsor | Saint Antoine University Hospital Academic / other |
| Locations | 1 site (Paris) |
| Status | Recruiting |
| Started | February 2010 |
| Main results expected | December 31, 2030 |
| Study ends | December 31, 2030 |
| Registry record updated | January 30, 2024 |
| Trial ID | NCT02453919 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this registry are adults aged 18 and older who are HIV-1 positive and have at least two cardiovascular risk factors.
✕Probably not a fit
Patients who do not have HIV or those who do not meet the cardiovascular risk factor criteria may not benefit from this registry.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The RECOVIH registry is an observational project that collects data from adults living with HIV who have additional cardiovascular risk factors and undergo cardiac examinations at the Cardiac Center of Saint Antoine Hospital. This registry aims to evaluate echocardiographic, coronarographic, and blood pressure abnormalities in this population. By maintaining anonymized data, the registry seeks to improve patient care through better risk stratification and understanding of the relationship between HIV and cardiovascular diseases. The findings from this registry may also contribute to research on optimal cardiac care for individuals living with HIV.
Why it matters
Potential benefit: If successful, this registry could enhance the understanding of cardiovascular risks in HIV patients, leading to improved patient care and management.
How similar studies have gone: While there is limited scientific evidence specifically addressing this population, similar observational studies have shown promise in understanding cardiovascular complications in patients with chronic conditions.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18 years of age or older * Known HIV-1 seropositivity for minimum of six months (confirmed by Elisa and Western Blot) * Underwent complete cardiac examination (echocardiography, ischemia test, ambulatory blood pressure monitoring) between 2005 and 2010 at the Cardiac Center in the Saint Antoine University Hospital in Paris, France * Presenting a minimum of two cardiovascular risk factors (HIV and a minimum of one other) according to the AFFSSAPS 2005 and Morlat Report 2013. * Willing and able to give informed consent to participate in the study Exclusion Criteria : * Refusal to give or sign informed consent * Not associated with a social security regime (no health insurance)
Where it's running
-
Division of Cardiology, Saint Antoine University Hospital
Paris, France Recruiting
Study contacts
- Study coordinator: Franck Boccara, MD, PhD
- Email: franck.boccara@aphp.fr
- Phone: +0033 (0) 1 49 28 20 00
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Mindfulness and behavior-change program to improve heart health in older adults with HIV
This project will test a text-message–enhanced mindfulness and behavior-change program to see if it reduces stress and cardiovascular risk in people aged 50+ living with HIV who have elevated psychological distress.
-
Educational text messages to improve heart health in people with HIV
This study tests if sending educational text messages can help people over 40 with HIV make better choices for their heart health.
-
Personalized wellness intervention for smoking cessation in adults living with HIV
This study tests a personalized program to help adults with HIV quit smoking and see if it works better than standard methods.
-
Abnormal menstrual bleeding in women on antithrombotic drugs after heart surgery
This study looks at whether women on blood thinners after heart surgery have abnormal menstrual bleeding and what factors might put some at higher risk.
-
AI-powered ECG to help diagnose and predict outcomes in heart disease
Researchers test an AI-enhanced ECG to help diagnose and predict outcomes for people with cardiovascular diseases.
-
Colchicine for preventing cardiovascular disease in adults with type 2 diabetes
A 24-week study will test whether low-dose colchicine can help protect blood vessels in adults with type 2 diabetes who have not yet developed artery disease, compared with a placebo.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.